| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3940(01)02111-5 |
| P698 | PubMed publication ID | 11585553 |
| P2093 | author name string | M Nishimura | |
| M Ohta | |||
| S Yamasaki | |||
| R Kaji | |||
| S Kuno | |||
| E Mizuta | |||
| I Mizuta | |||
| P2860 | cites work | A new concept in neurodegeneration: TNFalpha is a silencer of survival signals | Q33863128 |
| Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy | Q39305463 | ||
| Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter | Q40994192 | ||
| HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers | Q44017310 | ||
| Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese | Q47727081 | ||
| Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: No association with narcolepsy | Q48754471 | ||
| Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson's disease | Q64786053 | ||
| Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. | Q64902232 | ||
| Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis | Q71607261 | ||
| Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus | Q73194135 | ||
| P433 | issue | 1 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 1-4 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease | |
| P478 | volume | 311 |
| Q33932167 | Association of NQO1 and TNF polymorphisms with Parkinson's disease: A meta-analysis of 15 genetic association studies |
| Q36998952 | Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease |
| Q34810493 | Cytokine gene polymorphism in human disease: on-line databases, supplement 2. |
| Q35914948 | Cytokine polymorphism and its possible impact on cancer |
| Q34473323 | Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease |
| Q90705600 | Differential expression of miR-4492 and IL-10 is involved in chronic rhinosinusitis with nasal polyps |
| Q23916360 | Divergent roles for tumor necrosis factor-alpha in the brain |
| Q27498993 | Does neuroinflammation fan the flame in neurodegenerative diseases? |
| Q47765502 | Downregulation of miR-7116-5p in microglia by MPP+ sensitizes TNF-α production to induce dopaminergic neuron damage |
| Q33907156 | Effect of prolonged exposure to diesel engine exhaust on proinflammatory markers in different regions of the rat brain |
| Q38018496 | Genetic determinants of neuronal vulnerability to apoptosis. |
| Q37403825 | Helicobacter hypothesis for idiopathic parkinsonism: before and beyond. |
| Q42030555 | Human pluripotent stem cell derived midbrain PITX3(eGFP/w) neurons: a versatile tool for pharmacological screening and neurodegenerative modeling |
| Q85110030 | Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson’s disease in an Italian cohort |
| Q23916366 | Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease |
| Q37968039 | Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease |
| Q89720195 | Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study |
| Q27027973 | Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity |
| Q33353554 | Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease? |
| Q36919403 | Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention |
| Q24815148 | Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation |
| Q37741285 | Pharmacological therapy in Parkinson's disease: focus on neuroprotection |
| Q36165760 | Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation |
| Q35510197 | Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease. |
| Q24794457 | Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease |
| Q21093232 | TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease |
| Q48315546 | The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability. |
| Q38105903 | The role of inflammation in sporadic and familial Parkinson's disease |
| Q37897498 | Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system |
| Q37680121 | Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction |
| Q57472025 | Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients |
| Q34596492 | Viral parkinsonism. |
Search more.